ASPEN GROUP INC. DL-,001

Aspen, Lilly's distributor for Mounjaro in sub‑Saharan Africa, forecasts African sales of the diabetes and weight‑loss drug to top 2 billion rand in its 2027 financial year, driven by strong demand in South Africa and planned launches in Nigeria and Kenya pending approvals. South Africa's GLP‑1 market nearly doubled to 2.8 billion rand year‑on‑year, with Mounjaro's share rising to 53%. Aspen is also preparing a generic Ozempic rollout in selected markets but faces timing uncertainty due to API supply issues from an Indian supplier and is securing alternative sources and registrations. » More on finance.yahoo.com

Aspen Group increased adjusted operating profit by 46% to A$9.6m and revenue by 32% to A$141.1m. The company forecasts core earnings of A$66m for the current fiscal year, up 22% versus 2026. After the figures the stock climbed about 6.7%, continuing a pattern of earlier earnings-driven price gains. » More on de.investing.com

Shares of Aspen Insurance Holdings Ltd (AHL) rose to $36.43, hitting a 52-week high, while InvestingPro data indicate a price level slightly above fair value and revenue growth of 6.74% over the past twelve months. At the same time, it was reported that Sompo Holdings intends to acquire Aspen for $3.5 billion in cash (a 35.6% premium), while several analysts cut their earnings forecasts or price targets and expect a decline in net income for the current year. » More on de.investing.com